Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Jan 2005 Treatment of Family Members and Significant Others: All in the Family Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19-0501. Case and Commentary Jan 2005 All in the Family, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19a-0501. Case and Commentary Jan 2005 All in the Family, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19b-0501.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Jan 2005 Treatment of Family Members and Significant Others: All in the Family Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19-0501.
Case and Commentary Jan 2005 All in the Family, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19a-0501.
Case and Commentary Jan 2005 All in the Family, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005;7(1):111-116. doi: 10.1001/virtualmentor.2005.7.1.ccas19b-0501.